The Cannigma

MAY 17, 2022

According to a 2018 study, artists use cannabis to balance the extreme emotional states present during their creative process, and the impact of drug use on creativity was unique to each artist. 13 A 2018 study tested the effects of alpha and beta pinene on men and women by measuring their brain waves with an EEG test.

Terpenes 133

Terpenes Strains THC Oil 133

Canna Care Docs

DECEMBER 11, 2018

Ultimately, beyond increased access, a big reason that seniors are turning to cannabis is that it helps with a range of health issues. “Americans Who Smoke Marijuana By Age Group 2017 | Statistic” 2018. Accessed December 5 2018. Accessed December 5 2018. Let’s take a closer look. References.

Chronic Pain 76

Chronic Pain Sleep Clinical Trials Medicine 76

Peninsula Alternative Health

MAY 15, 2019

The huge difference between medical cannabis and traditional pharmaceuticals is that cannabis is quickly becoming accessible to treat conditions before clinical trials and standard dosing protocols have been established. 2018) Behind the smokescreen of medical cannabis [Dedi Meiri], TEDx Tel Aviv Retrieved from [link].

Conditions 89

Conditions Therapy Cannabinoids Epilepsy 89

Cannabis Law Report

AUGUST 21, 2019

A concurrent review by NHS England, which overseas budget, planning, and day-to-day operations of the commissioning side of the English health service has said more research and trials are needed, however. It also said the children’s experiences on medicinal cannabis in the should be taken into account as evidence of how well the drug works.

Clinical Trials 81

Clinical Trials Nerve Pain Medicine Epilepsy 81

Cannabis Law Report

SEPTEMBER 1, 2021

The company recently became the industry’s first firm to list on the NYSE American exchange and their psilocybin clinical trial for depression is making excellent progress. His background is a mix of cognitive psychology, clinical psychology and computer science.

Research and Development 102

Research and Development Therapy Clinical Trials Pharmaceutical 102

Cannabis Law Report

DECEMBER 14, 2019

million in the Melbourne cannabis firm in 2018. Export markets have also continued to open up, according to Bell and Smith, since the shipment of the drug out of the country was legalized in 2018. A 2018 report from Prohibition Partners has forecasted that medical cannabis in Australia could be worth US$2.13

Pharmaceutical 98

Pharmaceutical Patients Clinical Trials Hemp 98

Canna Law Blog

MARCH 4, 2020

In recent years, the United States has seen a proliferation of ketamine clinics. From 2015 to 2018, the number of clinics increased from 60 to 300; that number is undoubtedly higher today. That access would be available under the auspices of having a chronic, untreatable mood disorder.

Therapy 113

Therapy Legalization Chronic Pain DEA 113

LifeCannMD

MAY 27, 2025

2018, when the FDA approved Epidiolexthe first cannabis medication ever approved in the United States. Getting Legal Access in Florida : Your Medical Marijuana Card Let’s talk brass tacks for a minute. How do you actually get legal access to this stuff in Florida? The difference between CBD and THC.

CBD 52

CBD Oil Epilepsy Sleep 52

Cannabis Law Report

MAY 31, 2022

The only psychedelic drug that is approved (outside of clinical trials) for psychiatric use—as opposed to anesthesia—through the traditional medical system is Ketamine. 2022 Active FDA Clinical Trials and State-Regulated Systems. Active FDA Regulated Clinical Trials*. On March 5, 2019, the U.S. Schedule I.

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

Cannabis Law Report

NOVEMBER 13, 2019

Denmark is already leading the way by launching a Big Pharma modelled 4-year medical marijuana trial in early 2018, following a unanimous vote in Parliament. This ground-breaking trial has full parliamentary support, and will be evaluated in mid-2020. The roadmap ahead includes clinical trials and more research in Denmark.

Clinical Trials 78

Clinical Trials Research and Development Cultivation Patients 78

Cannabis Law Report

JULY 9, 2021

Beginning in 2018, the FDA has started to grant special designations to study the medicinal use of psilocybin via Breakthrough Therapy status. Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinical trials are currently under way.

Law 81

Law Therapy Clinical Trials Decriminalization 81

MedicalJane

JUNE 29, 2018

On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). Use of CBD in seizure prevention is well-documented with research ; and now, after conducting its own trials, the FDA appears to agree. Clinical trials show that Epidiolex significantly reduces seizure frequency.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Cannabis Law Report

SEPTEMBER 22, 2021

Access to Canopy Growth’s cannabinoid library including 335 derivatives and 14 patent families. Accelerated timelines to clinical trials and expansion of drug development pipeline. Phase 1 clinical trials are scheduled for Q3 2022 with Phase 2 trials expected in Q2 2023.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

SpeedWeed

DECEMBER 28, 2018

In my defense, 2018 has been a wild ride in the world of weed, a 12-month timespan which truly could be called “the best of times and the worst of times,” or perhaps just the highest and lowest of times. The Top 10 Cannabis Stories of 2018. But until then, here are the buzzes and bummers 2018 had to offer.

Pharmaceutical 40

Pharmaceutical Research and Development Legalization CBD 40

The Cannigma

MAY 6, 2021

If you have access to regulated cannabis that’s produced under acceptable standards, there’s no real reason to seek delta-8 products. The popularity of hemp can be traced back to the 2018 Farm Bill, a piece of legislation that effectively legalized hemp, which is defined as cannabis containing less than 0.3% Is Delta 8 THC legal?

THC 145

THC Cannabinoids Concentrates Hemp 145

Cannabis Law Report

JULY 1, 2021

Clinical trials repeatedly demonstrate their promise for treating mood, anxiety, and substance use disorders. In 2017, the FDA designated MDMA a breakthrough therapy for post-traumatic stress disorder, and in 2018 the agency identified psilocybin as a breakthrough for treatment-resistant depression.

Law 59

Law Policy Research and Development Clinical Trials 59

Cannabis Law Report

NOVEMBER 29, 2019

Different legislation across EU countries on prescribing cannabis-based medicines can hinder patients’ access to their treatment when they travel abroad, EUMCA said. Lack of clinical trials is a major reason why doctors are cautious about the drug.

Medicine 45

Medicine Clinical Trials Treatment Patients 45

The Cannigma

AUGUST 14, 2022

9 A 2018 study tested the effects of alpha and beta-pinene on men and women by measuring their brain waves with an EEG test. If you don’t have access to lab reports, smell the weed before you buy it. The post Best strains and terpenes for focus and flow state appeared first on The Cannigma.

Terpenes 128

Terpenes Strains THC Oil 128

Cannabis Law Report

MAY 12, 2022

Lophora has previously secured grant funding from the BioInovation Institute (Novo Nordisk Foundation) and continues to characterise its lead candidates, aiming to initiate clinical trials in 2023. Lophora is a drug-development company founded in 2018 in Copenhagen, Denmark. Lophora – www.lophora.com.

Medicine 52

Medicine Research and Development Clinical Trials Treatment 52

Miss Marijuana

FEBRUARY 7, 2025

THC) is federally legal, thanks to the 2018 Farm Bill. CBD , on the other hand, is generally more accessible. While more clinical trials are needed, THC has already been shown to help improve quality of life for those dealing with these conditions. When we talk about federal vs. state regulations , it gets interesting.

THC 52

THC CBD Chronic Pain Cannabinoids 52

Cannabis Law Report

MARCH 2, 2020

The UK government has eased import restrictions on medicinal cannabis, but has admitted it needs to do much more to improve access for patients. It will continue to engage with medical associations and patients to build evidence, using trials in the UK to accelerate our understanding of how medicinal cannabis can benefit patients.

Medicine 45

Medicine Research and Development Clinical Trials Patients 45

Cannabis Law Report

AUGUST 19, 2019

Access to medicinal cannabis for patients was legalised in Australia in 2016, allowing doctors to request permission to prescribe from the Australian government. This is at least due to the difficulty and cost involved in accessing a legal prescription. Patient access pathways.

Medicine 45

Medicine Patients Clinical Trials Access 45

Cannabis Law Report

AUGUST 7, 2022

In recent years, as more clinical trial results show that psychedelics can be used in conjunction with therapy to treat illnesses like depression and post-traumatic stress disorder, legislators pushed to make certain substances available in certain settings. But these substances remain illegal under federal law.

Law 74

Law Research and Development Therapy Treatment 74

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

MARCH 1, 2019

Natalie has worked with private hospitals and clinics in relation to medical malpractice claims, and assisted on cases involving medical devices product liability and clinical trials. Acting on a broad range of cases, all with a medical or injury element, usually on the instructions of insurers. Availability.

Medicine 45

Medicine Clinical Trials Patients Treatment 45

Cannabis Law Report

DECEMBER 21, 2021

Numinus also made important alliances in 2021, particularly with the Multidisciplinary Association for Psychedelic Studies (MAPS) on its compassionate access trial for MDMA-assisted therapy. While its psilocybin and MDMA trials progress, the company is expanding its psychedelics research laboratory.

Clinical Trials 52

Clinical Trials Therapy Treatment DEA 52

Cannabis Law Report

JANUARY 4, 2022

“I am so very proud of all Anebulo has achieved over the past 18 months, including building out a highly effective team, securing new intellectual property protection, preparing and starting a proof-of-concept clinical trial, advancing regulatory discussions with the U.S.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Cannabinoids 52

Cannabis Law Report

JULY 12, 2019

As reported in the Guardian, Analytical Cannabis emphasises the importance of this for those suffering from conditions such as chronic pain, epilepsy and neurological and psychiatric disorders who have long been seeking access to what they hope is a transformative medicine. Background to the legalisation of medical cannabis in the UK.

Epilepsy 40

Epilepsy Medicine Clinical Trials Chronic Pain 40

The Joint Blog

NOVEMBER 4, 2019

Healthcare providers play a critical role in facilitating patient access to medical cannabis. Understanding current attitudes and beliefs of providers may provide insight into the ongoing challenges they face as states expand access to medical cannabis. ” The full abstract of the study can be found below: Background.

Therapy 42

Therapy Clinical Trials Conditions Patients 42

MMJ Recs

NOVEMBER 20, 2023

Epidiolex was approved by the FDA in 2018 for the treatment of two rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome. CBD’s anti-seizure properties, demonstrated through clinical trials, have made it a game-changer in the epilepsy field.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

Cannabis Law Report

NOVEMBER 29, 2021

ATAI Life Sciences AG (NASDAQ: ATAI), the innovative mental health platform company I have started in 2018 and which is committed to unlocking the compelling potential of psychedelics, has announced this morning that it has bought an additional stake in COMPASS Pathways (NASDAQ: CMPS), bringing atai’s ownership in Compass beyond 20%.

Treatment 52

Treatment Clinical Trials Data Patients 52

Peninsula Alternative Health

MAY 15, 2019

The huge difference between medical cannabis and traditional pharmaceuticals is that cannabis is quickly becoming accessible to treat conditions before clinical trials and standard dosing protocols have been established. 2018) Behind the smokescreen of medical cannabis [Dedi Meiri], TEDx Tel Aviv Retrieved from [link]

Conditions 40

Conditions Therapy Cannabinoids Epilepsy 40

Cannabis Law Report

JULY 15, 2019

Law 33/2018 set the framework for the regulation of the use of cannabis-based medicinal products, preparations and substances that would effectively allow Portuguese patients to access medical cannabis What really has changed during the last year? Joana Albernaz Delgado. The hardest part has already been done.

Medicine 40

Medicine Clinical Trials Patients Chronic Pain 40

MMJ Recs

JULY 3, 2024

Federally, the 2018 Farm Bill decriminalized hemp-derived CBD with less than 0.3% This variability can pose challenges for medical marijuana patients seeking consistent access to safe and effective CBD products, as well as for businesses aiming to comply with a patchwork of state laws. THC, marking a significant shift toward legality.

CBD 52

CBD Research and Development Clinical Trials THC 52

Cannabis Law Report

DECEMBER 17, 2021

deletion syndrome in the 7MM covering United States, EU5 countries (Germany, France, Italy, Spain, and United Kingdom), and Japan from 2018 to 2030. Zynerba Pharmaceuticals is currently developing the Zygel in Phase II (ACTRN12619000673145; INSPIRE) of the clinical development in Children and Adolescents with 22q11.2 Deletion Syndrome.

Clinical Trials 40

Clinical Trials Research and Development Pharmaceutical Therapy 40

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. 2018 ; Frankhauser 2008 ). At the same time, the outlook on cannabis research data is largely positive. Bonini et al.

Research and Development 52

Research and Development Medicine Access Media 52

Cannabis Law Report

MAY 13, 2019

In nearly every jurisdiction where medicinal cannabis is legal, at least one medical professional is required to sign off for a person to access it. The number of jurisdictions allowing access to medicinal cannabis has been steadily increasing since the state of California introduced legislation in 1996. Gardiner , Judith A.

Medicine 45

Medicine Research and Development Clinical Trials Data 45